Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 2Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 80Rituximab 61Specimen Handling 53Doxorubicin 45Biopsy 45Vincristine 44Prednisone 41Magnetic Resonance Spectroscopy 40venetoclax 31obinutuzumab 29fludarabine 29ibrutinib 24Methotrexate 24Cytarabine 23Lenalidomide 22Dexamethasone 22merphos 19blinatumomab 19Bendamustine Hydrochloride 19Etoposide 18zanubrutinib 17acalabrutinib 17prednylidene 16fludarabine phosphate 16deltacortene 16Mercaptopurine 16X-Rays 15Calcium Dobesilate 15pegaspargase 14Nivolumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mitoxantrone × Lymphoid × 30 days × Clear all
NCT02101853 2026-06-03

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 3 Active not recruiting
669 enrolled 14 charts
Lymphoid

Burkitt Lymphoma

NCT05848687 2026-06-03

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Stanford University

Phase 1/2 Recruiting
90 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡